|Aeon Astron Europe B.V. (Aeon Astron B.V.) was incorporated in February 2008 in Leiden, the Netherlands. Aeon Astron B.V. is a wholly owned subsidiary of BOBC.|
Aeon Astron B.V. is dedicated to global sales and marketing for high value added and novel medical devices, as well as research and development of biomaterial and regenerative medicine for ophthalmological applications. These devices include ologen® Collagen Matrix, BioCornea, and BioLens, which are designed not only for eye tissue repair and vision improvement but also for improving the quality of life.
Aeon Astron B.V. holds CE certificates, FDA-510 K, and other registrations from many countries for ologen® Collagen Matrix and Aongen™.
|By focusing on an international marketing network, this European operation will play a key role to sustain the growing expansive network infrastructure in future developments. This will enable BOBC to have more international exposure and to recruit talented staff for all divisions.|
Aeon Astron B.V. is able to apply for and to obtain European Governmental Subsidizations as well as strong national and international cooperation with the key-opinion leaders in ophthalmology. Aeon Astron B.V. is a supporting Glaucoma Industry Member of the World Glaucoma Association (WGA).